abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents an anticancer chemotherapeutic agent containing a combination of a cholestanol derivative presented by the formula n , n wherein G represents GlcNAc-Gal- or GlcNAc-, or its cyclodextrin inclusion compound, and irinotecan. n EFFECT: anticancer chemotherapeutic agent has excellent efficacy and fewer side effects. n 7 cl, 6 ex, 9 dwg |